We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$589M
Cap. Flow %
4.16%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$134M
2
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$120M
3
KKR icon
KKR & Co
KKR
+$113M
4
MDLZ icon
Mondelez International
MDLZ
+$103M
5
AXS icon
AXIS Capital
AXS
+$97.1M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$303M
2
BSX icon
Boston Scientific
BSX
+$127M
3
LEN icon
Lennar Class A
LEN
+$95.9M
4
MLM icon
Martin Marietta Materials
MLM
+$94.6M
5
CL icon
Colgate-Palmolive
CL
+$92M

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Industrials 12.27%
4 Healthcare 11.72%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWTX icon
326
Edgewise Therapeutics
EWTX
$4.26B
$4.68M 0.03%
+148,426
New +$4.28M
MOD icon
327
Modine Manufacturing
MOD
$13.1B
$4.59M 0.03%
+21,167
New +$3.98M
SMTC icon
328
Semtech
SMTC
$12.8B
$4.52M 0.03%
58,824
-218,810
-79% -$18M
ITT icon
329
ITT
ITT
$17.1B
$4.51M 0.03%
+23,684
New +$4.51M
EEFT icon
330
Euronet Worldwide
EEFT
$3.02B
$4.47M 0.03%
+67,323
New +$4.82M
IRON icon
331
Disc Medicine
IRON
$2.89B
$4.39M 0.03%
+68,687
New +$4.77M
CNTA
332
DELISTED
Centessa Pharmaceuticals
CNTA
$4.34M 0.03%
+109,327
New +$2.8M
ITW icon
333
Illinois Tool Works
ITW
$78.3B
$4.32M 0.03%
+16,610
New +$4.52M
KTOS icon
334
Kratos Defense & Security Solutions
KTOS
$9.04B
$4.17M 0.03%
59,140
+51,653
+690% +$4.95M
PTEN icon
335
Patterson-UTI
PTEN
$4B
$4.17M 0.03%
+384,925
New +$3.3M
KVYO icon
336
Klaviyo
KVYO
$5.24B
$4.02M 0.03%
206,730
-2,487
-1% -$53.3K
RAPP
337
Rapport Therapeutics
RAPP
$2.04B
$4M 0.03%
+127,783
New +$3.59M
GGG icon
338
Graco
GGG
$12.1B
$3.79M 0.03%
44,730
+25,710
+135% +$2.28M
INTU icon
339
Intuit
INTU
$79.3B
$3.65M 0.03%
8,448
+2,860
+51% +$1.36M
FIGR
340
Figure Technology Solutions
FIGR
$6.96B
$3.27M 0.02%
96,215
-303,785
-76% -$13.1M
RUN icon
341
Sunrun
RUN
$2.73B
$3.19M 0.02%
235,006
+84,237
+56% +$1.4M
FROG icon
342
JFrog
FROG
$10.5B
$3.19M 0.02%
+67,882
New +$3.33M
MNST icon
343
Monster Beverage
MNST
$92.4B
$3.17M 0.02%
43,747
-275,375
-86% -$21.7M
GPK icon
344
Graphic Packaging
GPK
$3.23B
$3.15M 0.02%
+316,966
New +$3.99M
CMCSA icon
345
Comcast
CMCSA
$85.1B
$3.12M 0.02%
+108,729
New +$3.25M
IBP icon
346
Installed Building Products
IBP
$5.98B
$3.05M 0.02%
+11,506
New +$3.45M
AMD icon
347
Advanced Micro Devices
AMD
$888B
$3.01M 0.02%
+14,791
New +$3.16M
CBT icon
348
Cabot Corp
CBT
$4.59B
$3.01M 0.02%
39,933
+6,869
+21% +$499K
XLV icon
349
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
$3M 0.02%
+20,458
New +$3.16M
HEI.A icon
350
HEICO Corp Class A
HEI.A
$34.6B
$2.99M 0.02%
+14,178
New +$3.49M
12 13
14
15 16

Similar funds

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $14.1B AUM 25.71% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.